129 related articles for article (PubMed ID: 28680203)
1. Role of FDG PET/CT in Diagnostic Evaluation of Granulocytic Sarcomas: A Series of 12 Patients.
Chandra P; Dhake S; Purandare N; Agrawal A; Shah S; Rangarajan V
Indian J Nucl Med; 2017; 32(3):198-202. PubMed ID: 28680203
[TBL] [Abstract][Full Text] [Related]
2. Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Initial results.
Aschoff P; Häntschel M; Oksüz M; Werner MK; Lichy M; Vogel W; Pfannenberg C
Nuklearmedizin; 2009; 48(5):185-91. PubMed ID: 19710955
[TBL] [Abstract][Full Text] [Related]
3. Ocular Granulocytic Sarcoma as an Initial Clinical Presentation of Acute Myeloid Leukemia Identified on Flurodeoxyglucose Positron Emission Tomography/Computed Tomography.
Chandra P; Purandare N; Shah S; Agrawal A; Rangarajan V
Indian J Nucl Med; 2017; 32(1):59-60. PubMed ID: 28242990
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. ¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
Stölzel F; Röllig C; Radke J; Mohr B; Platzbecker U; Bornhäuser M; Paulus T; Ehninger G; Zöphel K; Schaich M
Haematologica; 2011 Oct; 96(10):1552-6. PubMed ID: 21685468
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT.
Makis W; Rakheja R; Lavoie J; Hickeson M
Nucl Med Mol Imaging; 2012 Jun; 46(2):119-24. PubMed ID: 24900045
[TBL] [Abstract][Full Text] [Related]
8. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
[TBL] [Abstract][Full Text] [Related]
9. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
[TBL] [Abstract][Full Text] [Related]
10.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract][Full Text] [Related]
11. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of
Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L
Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy.
Ueda K; Ichikawa M; Takahashi M; Momose T; Ohtomo K; Kurokawa M
Leuk Res; 2010 Sep; 34(9):1239-41. PubMed ID: 20493526
[TBL] [Abstract][Full Text] [Related]
14. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
15. Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Picardi M; Soricelli A; Grimaldi F; Nicolai E; Gallamini A; Pane F
Ann Oncol; 2011 Mar; 22(3):671-680. PubMed ID: 20693297
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
17. 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution.
Partridge S; Timothy A; O'Doherty MJ; Hain SF; Rankin S; Mikhaeel G
Ann Oncol; 2000 Oct; 11(10):1273-9. PubMed ID: 11106116
[TBL] [Abstract][Full Text] [Related]
18. 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma.
Delbeke D; Martin WH; Morgan DS; Kinney MC; Feurer I; Kovalsky E; Arrowsmith T; Greer JP
Mol Imaging Biol; 2002 Jan; 4(1):105-14. PubMed ID: 14538054
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
